Shopping Cart

Your shopping cart is currently empty

BAY-850

Name: BAY-850
Brand: TargetMol
SKU: T14510
Price: 44 USD
Availability: InStock
Rating: 5 (10 reviews)

😃Good

Catalog No. T14510Cas No. 2099142-76-2

BAY-850 is a selective and potent inhibitor of adenosine triphosphatase family protein 2 (ATAD2) (IC50: 166 nM) that inhibits ovarian cancer growth and metastasis in in vitro and in vivo models.

BAY-850

😃Good

Purity: 98%

Catalog No. T14510Cas No. 2099142-76-2

BAY-850 is a selective and potent inhibitor of adenosine triphosphatase family protein 2 (ATAD2) (IC50: 166 nM) that inhibits ovarian cancer growth and metastasis in in vitro and in vivo models.

Pack Size	Price	USA Warehouse	Global Warehouse	Quantity
1 mg	$44	-	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:98%

Appearance:Solid

Color:White to Yellow

Resource Download

COA HPLC

Product Introduction

Bioactivity

Description	BAY-850 is a selective and potent inhibitor of adenosine triphosphatase family protein 2 (ATAD2) (IC50: 166 nM) that inhibits ovarian cancer growth and metastasis in in vitro and in vivo models.
Targets&IC50	ATAD2:166 nM, tetra-acetylated peptide:157 nM, tetra-acetylated peptide:115 nM (Kd)
In vitro	In a TR-FRET assay, BAY-850 competes with the binding of a mono-acetylated Histone H4 N-terminal peptide to ATAD2 BD, showing an IC50 of 166 nM. BAY-850 displaces the tetra-acetylated peptide with an IC50 of 157 nM and a KD of 115 nM, respectively. The unprecedented isoform selectivity of BAY-850 suggests a mode of action different from those exhibited by canonical BD inhibitors[1].

Chemical Properties

Molecular Weight	654.24
Formula	C₃₈H₄₄ClN₅O₃
Cas No.	2099142-76-2
Smiles	COc1cc(Cl)c(cc1-c1ccc(CN[C@H](C)c2ccc(C)cc2)o1)C(=O)N[C@@H](CN[C@@H]1CC[C@H](N)CC1)Cc1ccc(cc1)C#N
Relative Density.	1.24 g/cm3 (Predicted)

Storage & Solubility Information

Storage

store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

H2O: <0.1 mg/mL (Insoluble)

DMSO: 50 mg/mL (76.42 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (7.64 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	1.5285 mL	7.6425 mL	15.2849 mL	76.4246 mL
5 mM	0.3057 mL	1.5285 mL	3.0570 mL	15.2849 mL
10 mM	0.1528 mL	0.7642 mL	1.5285 mL	7.6425 mL
20 mM	0.0764 mL	0.3821 mL	0.7642 mL	3.8212 mL
50 mM	0.0306 mL	0.1528 mL	0.3057 mL	1.5285 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc